Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-14

Clinical Trial Update: Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice

View source ↗

Summary

Pfizer-sponsored clinical trial update shows real-world effectiveness of tofacitinib for psoriatic arthritis in routine clinical practice. Results were posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Psoriatic Arthritis | Status: COMPLETED | Results posted: 2025-10-14